Abstract:This paper describes the goals of the American Society of Health-System Pharmacists' Pharmacy Practice Model Initiative (PPMI) and its recommendations for health-system pharmacy practice transformation to meet future patient care needs and elevate the role of pharmacists as patient care providers. PPMI envisions a future in which pharmacists have greater responsibility for medication-related outcomes and technicians assume greater responsibility for product-related activities. Although the PPMI recommendations… Show more
“…Published in this issue of the journal is an ACCP commentary on the ASHP Pharmacy Practice Model Initiative (PPMI). 1 Overall and as detailed in the commentary, the objectives of PPMI and list of recommendations from summit participants are well aligned with existing positions of ACCP, and there is little to criticize relative to those broad goals. Evolving the practice of health-system pharmacy toward greater patient-centered care delivery that assumes accountability for medication-related outcomes and promotes the appropriate use of technology, technicians, and informatics to shift pharmacist time to higher-value activities is consistent with the advancement of clinical pharmacy.…”
mentioning
confidence: 87%
“…Published in this issue of the journal is an ACCP commentary on the ASHP Pharmacy Practice Model Initiative (PPMI) . Overall and as detailed in the commentary, the objectives of PPMI and list of recommendations from summit participants are well aligned with existing positions of ACCP, and there is little to criticize relative to those broad goals.…”
“…Published in this issue of the journal is an ACCP commentary on the ASHP Pharmacy Practice Model Initiative (PPMI). 1 Overall and as detailed in the commentary, the objectives of PPMI and list of recommendations from summit participants are well aligned with existing positions of ACCP, and there is little to criticize relative to those broad goals. Evolving the practice of health-system pharmacy toward greater patient-centered care delivery that assumes accountability for medication-related outcomes and promotes the appropriate use of technology, technicians, and informatics to shift pharmacist time to higher-value activities is consistent with the advancement of clinical pharmacy.…”
mentioning
confidence: 87%
“…Published in this issue of the journal is an ACCP commentary on the ASHP Pharmacy Practice Model Initiative (PPMI) . Overall and as detailed in the commentary, the objectives of PPMI and list of recommendations from summit participants are well aligned with existing positions of ACCP, and there is little to criticize relative to those broad goals.…”
“…Pharmacy as a profession has been evolving from the role of providing medication to one focused on the delivery of clinical services working side by side with other healthcare professionals 1 . In particular, hospital pharmacists have extended their scope of practice to meet patient needs, often specializing in particular clinical areas to target more complex groups of patients 2 …”
What is known and objective
A framework to evaluate the impact of clinical pharmacists in intensive care units (ICUs) in Chile has not yet been established. This study evaluates the cost avoidance and cost‐benefit ratios of clinical pharmacist interventions in terms of treatment optimization in an adult ICU in southern Chile.
Methods
Clinical pharmacist interventions in a multidisciplinary adult ICU were assessed between January and December 2019. Only interventions suggested by pharmacists and accepted by the healthcare team were included in the analysis. Interventions were classified into six categories, and cost avoidance (in US dollars) was calculated for each category using a systematic validated approach. A cost‐benefit ratio for clinical pharmacy services in the adult ICU was also calculated.
Results and discussion
Over the 12‐month period, 505 interventions were performed in 169 patients, of whom 62% were male. Interventions were classified into the following six categories: adverse drug event prevention (18%), which led to $87 882 in savings; resource utilization (ie change in medication route) (10%), which led to $50 525 in savings; individualization of patient care (ie dose adjustment) (36%), which led to $57 089 in savings; prophylaxis (ie initiation of stress ulcer prophylaxis) (<1%), which led to $167 in savings; hands‐on care (ie bedside monitoring) (23%), which led to $57 846 in savings; and administrative and supportive tasks (ie patient own medication evaluation) (13%), which led to $9988 in savings. The total cost savings over the year‐long period were $263 500, resulting in a cost‐benefit ratio of 1:24.2.
What is new and conclusion
The participation of a clinical pharmacist in a multidisciplinary ICU team reduces healthcare expenditures through treatment optimization translated into cost avoidance. This study has corroborated prior evidence that clinical pharmacist involvement in ICUs provides economic value and quality assurance in healthcare settings.
“…The 2013 Certification Affairs Committee tried to identify many of the issues faced by clinical pharmacy specialists since the development of the Pharmacy Practice Model Initiative, now known as the Practice Advancement Initiative (PAI) . These initiatives were separately focused on either inpatient practice or ambulatory practice, but given the alternative viewpoint contributed by Potter and colleagues, it is apparent that the issues raised by the committee affect the entire continuum of patient care …”
Section: Author's Replymentioning
confidence: 99%
“…The American Society of Health‐System Pharmacists' Pharmacy Practice Model Initiative (PPMI) aims to develop and disseminate pharmacy practice models that optimize the use of pharmacists as direct care providers . In their commentary, Jacobi and colleagues highlight opportunities and challenges presented through the PPMI and draw attention to potential negative consequences for clinical pharmacy specialists . We present the transplant specialist perspective.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.